Emerging Cell Therapies: Cancer, Autoimmune Diseases, and Beyond (C2)
March 5-8, 2028  | Fairmont Hotel Vancouver, Vancouver, BC, Canada
Georg A Schett, Marcela V Maus and Gilles Besin
* Session Chair † Invited but not yet accepted | Program current as of November 22, 2026 9 PM | For the most up-to-date details, visit https://www.keystonesymposia.org
Sunday, March 5, 2028
4:00–8:00 PM Registration
6:00–8:00 PM Welcome Mixer
Monday, March 6, 2028
7:30–8:30 AM Breakfast
8:30–8:40 AM Welcome Remarks
8:40–9:30 AM Keynote Address
  Carl H June †, University of Pennsylvania
A Perspective on the Future of Cell Therapy in Medicine
 
9:30–11:45 AM New Molecular Technologies in Cell Therapy
  Crystal L. Mackall †, Stanford University
Overcoming Macrophage Mediated Clearance of CAR
 
  Robbie G. Majzner, Dana Farber Cancer Institute
Synthetic Downstream Signaling Molecules in CARs
 
  Aude G. Chapuis, Fred Hutchinson Cancer Research Center
CD8-Mediated Co-Stimulation to Enhance TCR-Engineered T-Cells
 
  Sònia Guedan, Universitat de Barcelona
Fit to Fight: Engineering CAR-T Cells to Overcome Dysfunction and Tumor Escape
 
  Short Talk(s) Chosen from Abstracts
 
10:00–10:20 AM Coffee Break
11:55–12:55 PM Meet-the-Editor
12:55–2:00 PM Poster Setup
12:55–2:30 PM On Own for Lunch
2:00–10:00 PM Poster Viewing
2:30–4:30 PM Symposia Spotlight 1: Efficacy and Safety of Cell Therapy in Autoimmune Disease
  Short Talks Chosen from Abstracts
 
4:30–5:00 PM Coffee Available
5:00–7:00 PM CAR T-Cell Therapy in Autoimmune Disease
  Dinesh Khanna, University of Michigan
CAR T-Cell Treatment in Immune-Mediated Fibrotic Diseases
 
  Raffaella Greco, IRCCS San Raffaele Scientific Hospital
Guidelines for the Treatment of AID by CAR T-Cells
 
  Georg A Schett, Uniklinikum Erlangen
Long-Term Effects of CAR T-Cell in the Treatment of Lupus
 
  Short Talk(s) Chosen from Abstracts
 
7:00–8:00 PM Social Hour with Dinner
7:30–10:00 PM Posters
Tuesday, March 7, 2028
7:30–8:30 AM Breakfast
8:00–8:30 AM Poster Setup
8:15–5:00 PM Poster Viewing
8:30–11:30 AM New Technologies in Cell Therapy
  Jeffrey A. Bluestone, University of California, San Francisco
Antigen-Specific CAR Treg in Rheumatoid Arthritis
 
  Aimee S. Payne, Columbia University
Antigen-Specific Cellular Immunotherapies for Autoimmunity: Lessons from Phase 1 Studies
 
  Maximilian F Konig, The Johns Hopkins University School of Medicine
Precision Targeting of Autoreactive B Cells Using Engineered T Cell Receptors
 
  Gilles Besin, Valerio Therapeutics
Chances of LNP-based CAR Generation in Cancer and Autoimmune Disease
 
  Short Talk(s) Chosen from Abstracts
 
9:30–9:50 AM Coffee Break
11:30–12:30 PM Lunch
12:00–2:30 PM Posters
3:00–4:30 PM Career Roundtable
4:30–5:00 PM Coffee Available
5:00–7:00 PM Predictors of Outcomes in CAR T Cells
  Speaker to be Announced
 
  Juliane Gust, Seattle Children's Research Institute
Neuroimaging of CNS Toxicities after CAR
 
  Speaker to be Announced
 
  Short Talk(s) Chosen from Abstracts
 
7:00–8:00 PM On Own for Dinner
Wednesday, March 8, 2028
7:30–8:30 AM Breakfast
8:30–11:30 AM Advances in Targeting Solid Tumors by CAR
  Marcela V Maus, Harvard Medical School
Advances in CAR T-Cell Treatment of Pancreatic Cancer
 
  Christopher A. Klebanoff, Memorial Sloan Kettering Cancer Center
Public Neoantigen Targeting using TCR Gene Therapy
 
  Christine E. Brown, Beckman Research Institute, City of Hope
CAR-Therapy of Brain Tumors
 
  Franco Locatelli †, Ospedale Pediatrico Bambino Gesù
Developments in the Treatment of Medulloblastoma by CAR T-Cells
 
  Short Talk(s) Chosen from Abstracts
 
9:30–9:50 AM Coffee Break
11:40–12:40 PM Panel Discussion: Perspective on in vivo CAR T Cell Therapy in Cancer and Autoimmune Diseases
12:40–2:30 PM On Own for Lunch
2:30–4:30 PM Symposia Spotlight 2: New Methods to Foster Efficacy and Predict the Response of Cell Therapy in Cancer
  Short Talks Chosen from Abstracts
 
4:30–5:00 PM Coffee Available
5:00–6:45 PM New Disease Targets for CARs
  Dominic C. Borie †, Cue Biopharma
CAR T-Cell Therapy of Stiff Person Syndrome
 
  James Howard Jr. †, University of North Carolina
CAR T-Cell Therapy of Myasthenia Gravis
 
  Marion Subklewe, LMU - Klinikum of the University of Munich
Targeting Acute Myeloid Leukemia
 
  Short Talk(s) Chosen from Abstracts
 
6:45–7:00 PM Meeting Wrap-Up: Outcomes and Future Directions
7:00–8:00 PM Social Hour with Dinner
8:00–11:00 PM Entertainment
8:00–11:00 PM Cash Bar
Thursday, March 9, 2028
12:00–11:59 PM Departure